According to a new report from Intel Market Research, the global Pipe Fittings market was valued at USD 15,760 million in 2025 and is projected to reach USD 21,060 million by 2032, growing at a steady CAGR of 4.3% during the forecast period (2025–2032). This growth is primarily driven by increasing investments in water infrastructure, construction activities, and the expansion of oil & gas exploration.
Read MoreThe global Chlorhexidine Gluconate Solution market was valued at USD 167 million in 2025 and is projected to reach USD 204 million by 2032, exhibiting a CAGR of 2.9% during the forecast period.
Read MoreAccording to a new report from Intel Market Research, the global Special Graphite market was valued at USD 1,547 million in 2024 and is projected to reach USD 2,291 million by 2032, growing at a CAGR of 5.9% during the forecast period (2025–2032). This steady growth is driven by increasing demand across high-tech industries including electronics, aerospace, nuclear power, and metallurgy, coupled with advancements in material science and manufacturing technologies.
Read MoreAccording to a new report from Intel Market Research, the global brass faucets market was valued at USD 12.36 billion in 2025 and is projected to reach USD 17.48 billion by 2032, growing at a steady CAGR of 5.2% during the forecast period (2025–2032). This sustained expansion is propelled by the relentless pace of residential and commercial construction activity globally, rising consumer disposable income, and evolving preferences for durable, aesthetically pleasing, and water-efficient plumbing fixtures.
Read MoreAccording to a new report from Intel Market Research, the global Calcium Channel Blocker (CCB) market was valued at USD 71.5 million in 2025 and is projected to reach USD 80.4 million by 2032, growing at a CAGR of 1.7% during the forecast period (2025–2032). This steady expansion is primarily attributed to the escalating global prevalence of cardiovascular diseases, an aging demographic, and ongoing clinical research validating the long-term efficacy and safety profile of these well-established therapeutics. This growth persists despite market saturation and the patent expiry of several major drugs, underscoring the enduring clinical value of CCBs in modern cardiology.
Read More